Blister and bottle packaging, and cold chain distribution, are current investment targets
Packaging Coordinators, Inc., the business being funded by Frazier Healthcare, a private equity firm, and others, has absorbed its latest acquisition, AndersonBrecon Packaging, from AmerisourceBergen, and is moving forward with barely a hiccup, to hear the company tell it. Most recently, it had a ribbon-cutting ceremony at its Rockford, IL, facilities (the former HQ of AndersonBrecon; PCI itself is headquartered in Philadelphia), while simultaneously bringing online new blister-packaging capacity (using Uhlmann machines) and new bottling capacity (using IMA machines). In addition, the company has expanded its temperature-controlled storage and distribution capacity by 250 pallets, now totaling 1,000 pallets. Peter Belden, GM of the Rockford facility (see photo) led the ribbon-cutting.
PCI is moving rapidly along three paths, according to Justin Schroeder, senior director at the firm: expanded clinical and investigational-drug packaging and logistics; biologics (including autoinjector assembly); and serialized packaging/labeling to meet national and international regulatory requirements. Schroeder says that while the company has been serializing products for clients in Europe for a couple years, it is now qualifying vendors to provide serialization at its Rockford and other facilities.
Having previously picked up some assets from Catalent Pharma Solutions, PCI now encompasses 14 facilities in the US and Europe, over 1 million sq. ft of manufacturing space, and over 4,000 associates.
Understanding the FDA's Exemption for DSCSA Compliance
November 12th 2024In the quest for achieving full traceability, the exemption applies to certain trading partners under the Act, and postpones enforcement of final compliance requirements while acknowledging progress and ongoing challenges.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.